Contact 01 58 86 39 60   |   contact@institut-hypercube.org
Institut HyperCube
  • ABOUT US
  • PROJECTS
  • PARTNERS
  • PUBLICATIONS
  • FEATURED NEWS
    • PRESS
    • EVENTS
  • SUPPORT US
    • HOW TO SUPPORT
    • MAKE A DONATION
  • CONTACT
  • Français

Acute Myeloid Leukemia

EORTC_Logo

 

ACUTE MYELOID LEUKEMIA

Treating Acute Myeloid Leukemia

Context

Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. The word "acute" in acute myelogenous leukemia denotes the disease's rapid progression. It's called myelogenous leukemia because it affects a group of white blood cells called the myeloid cells, which normally develop into the various types of mature blood cells, such as red blood cells, white blood cells and platelets. There is more than one type of treatment, including: Chemotherapy, the use of anticancer drugs -- often two or three -- such as cytarabine, anthracycline drugs, 6-thioguanine, hydroxyurea, or prednisone. Radiation therapy, the use of high-energy radiation to kill cancer cells. A bone marrow transplant, which involves use of high doses of chemotherapy and possibly radiation, followed by a transplant of bone-forming stem cells.

Purpose of the study

Assessing the efficiency of a new treatment

Results to date

Research completed with insufficient results. A further research program is being envisaged

Other partners on this project
Bearingpoint_logo
lung

Lung Cancer

13 May 2016

21099-1426676754015-slide

Rett Syndrom

13 May 2016

Porphyria

13 May 2016

poumons_0_0

Aspergillosis

14 May 2016

Institut HyperCube
  • ABOUT US
  • CONTACT
  • LEGAL
Copyright ©2015 Institut HyperCube. Tous droits réservés